8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported)                  October 31, 2008
Hydromer, Inc. (Exact name of registrant as specified in its chapter)
New Jersey (State or other jurisdiction of incorporation)	0-10683 (Commission File Number)	22-2303576 (IRS Employer Identification No.)

35 Industrial Parkway Branchburg, N.J. (Address of principal executive offices) 08876 (Zip Code)

Registrant's telephone number, including area code                (908) 722 – 5000

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

(  )  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

(  )  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

(  )  Pre-commencement communications pursuant to Rule 14-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

(  )  Pre-commencement communications pursuant to Rule 13e-4© under the Exchange Act (17 CFR 240-13e-4(c))

- 1 - -

Item 8.01. Other Events

Press Release Announcing that Hydromer, Inc. enters Taiwanese Market.

EXHIBIT INDEX

Exhibit No.                            Description of Exhibit

99.35                           Press Release issued October 31, 2008

- 2 - -

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	Hydromer, Inc.  Registrant  /s/ Robert Y. Lee
Date October 31, 2008	Robert Y. Lee Chief Financial Officer

- 3 - -

EX-99.35

[Mis

Hydromer, Inc.	35 Industrial Parkway;  Branchburg, NJ  08876;  U.S.A.
	Tel: (908) 722-5000 • Fax: (908) 526-3633 • http://www.hydromer.com
	Video Conferencing IP Address: video.hydromer.com

PRESS RELEASE:  The following is available for immediate release:

Branchburg, New Jersey; October 31, 2008

From:	Hydromer, Inc.
	35 Industrial Parkway
	Branchburg, New Jersey 08876-3424
Contact:	Martin von Dyck, ExecutiveVice President
	(908) 722-5000

Hydromer, Inc. enters Taiwanese Market

Hydromer, Inc. (HYDI.OB – OTC BB), announces that it has entered into a Sales Representation Agreement with David Lu and Corp. in Taipei, Taiwan.

Under the terms of this relationship, David Lu and Corp will represent and negotiate medical Coating Services and Royalty/Fee Based Agreements in Taiwan.  The primary focus will be in the application of Hydromer’s proprietary and patented Hydromer® hydrophilic coatings on various Pebax® cardiovascular, neurovascular and similar microcatheters catheters under strict FDA cGMP and ISO 13485-2003 conditions.

“This Agreement will provide Hydromer with access to the lucrative Taiwanese medical device market.”, commented Martin von Dyck, Executive Vice President of Hydromer, Inc., adding, “The David Lu and Corp. will also be responsible for negotiating all coating services and IP protecting agreements within Taiwan, subject to final approval by Hydromer.”

David Lu and Corp. is a Sales Organization that specializes in high technology coatings.  It is headquartered in Taipei, Taiwan.  http://hi.baidu.com/hydromer

Pebax ® is a registered trademark of Arkema.

Hydromer, Inc. is a technology-based company involved in the research and development, manufacture and commercialization of specialized polymer and hydrogel products for medical device, pharmaceutical, animal health, cosmetic, personal care, and industrial uses.  For the latest information about Hydromer, Inc. and its products, please visit our web site at http://www.hydromer.com.